Aplab Limited
Aplab Limited Fundamental Analysis
Aplab Limited (APLAB.BO) shows moderate financial fundamentals with a PE ratio of 27.00, profit margin of 15.12%, and ROE of 80.01%. The company generates $0.5B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 54.2/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze APLAB.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentAPLAB.BO demonstrates superior asset utilization.
Valuation Score
ModerateAPLAB.BO shows balanced valuation metrics.
Growth Score
ModerateAPLAB.BO shows steady but slowing expansion.
Financial Health Score
ModerateAPLAB.BO shows balanced financial health with some risks.
Profitability Score
ModerateAPLAB.BO maintains healthy but balanced margins.
Key Financial Metrics
Is APLAB.BO Expensive or Cheap?
P/E Ratio
APLAB.BO trades at 27.00 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, APLAB.BO's PEG of 0.03 indicates potential undervaluation.
Price to Book
The market values Aplab Limited at 14.68 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 20.37 times EBITDA. This signals the market has high growth expectations.
How Well Does APLAB.BO Make Money?
Net Profit Margin
For every $100 in sales, Aplab Limited keeps $15.12 as profit after all expenses.
Operating Margin
Core operations generate 4.33 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $80.01 in profit for every $100 of shareholder equity.
ROA
Aplab Limited generates $15.01 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Aplab Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Aplab Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
APLAB.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
27.00
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.03
vs 25 benchmark
P/B Ratio
Price to book value ratio
14.68
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.72
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.42
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.24
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.80
vs 25 benchmark
ROA
Return on assets percentage
0.15
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How APLAB.BO Stacks Against Its Sector Peers
| Metric | APLAB.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 27.00 | 26.71 | Neutral |
| ROE | 80.01% | 1311.00% | Weak |
| Net Margin | 15.12% | -29317.00% (disorted) | Strong |
| Debt/Equity | 1.42 | 0.75 | Weak (High Leverage) |
| Current Ratio | 1.24 | 10.53 | Neutral |
| ROA | 15.01% | -1537638.00% (disorted) | Strong |
APLAB.BO outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Aplab Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
EPS CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
FCF CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure